Localization of Messenger RNA for Mr 72,000 and 92,000 Type IV Collagenases in Human Skin Cancers by in Situ Hybridization

Cancer Research

Volumn 52, Issue 5, 1992, Pages 1336-1341

  Huhtala, Piricko ^c   Hurskainen, Tina ^c   Tryggvason, Karl ^a,c  

^a FINSEN LABORATORY   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGENASE; MESSENGER RNA;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; CONTROLLED STUDY; DEGRADATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MACROPHAGE; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STROMA;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; GELATINASE B; HUMAN; MICROBIAL COLLAGENASE; MOLECULAR WEIGHT; NUCLEIC ACID HYBRIDIZATION; RNA, MESSENGER; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T;

EID: 0026589277     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and an giogenesis: an imbalance of positive and negative regulation. Cell, 64: 327-336,1991.
2. Tryggvason, K., Hoyhtya, M., and Salo, T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim. Biophys. Acta, 907: 191-217, 1987.
3. Alexander, C. M., and Werb, Z. Proteinases and extracellular matrix remodelling. Curr. Opin. Cell. Biol., 1:974-982,1989.
4. Birkedal-Hansen, H. From tadpole collagenase to a family of matrix metal-loproteinases. J. Oral Pathol., 17:445-451,1988.
5. Danø, K., Andreasen, P. A., Grøndahl-Hansen, J., Kristensen P., Nielsen, L. S., and Skriver, L. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res., 44:139-266,1985.
6. Blasi, F., Vassalli J-D., and Dane, K. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell Biol., 104:801-805,1987.
7. Nakajima, M., Irimura, T., and Nicolson, G. L. Heparanase and tumor metastasis. J. Cell. Biochem., 36:157-167, 1988.
8. Liotta, L. A., Tryggvason, K., Garbisa, S., Robey, P. G., and Abe, S. Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry, 20:100-104,1981.
9. Salo, T., Liotta, L. A., and Tryggvason, K. Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. J. Biol. Chem., 258:3058-3063,1983.
10. Hibbs, M. S., Hasty, K. A., Seyer, J. M., Kang, A. H., and Mainardi, C. L. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J. Biol. Chem., 260:2493-2500,1985.
11. Fessler, L., Duncan, K., Fessler, J. H., Salo, T., and Tryggvason, K. Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J. Biol. Chem., 259:9783-9789,1984.
12. Murphy, G., Ward, R., Hembry, R. M., Reynolds, J. J., Kuhn, K., and Tryggvason, K. Characterization of gelatinase from pig polymorphonuclear leucocytes. Biochem. J., 258:463-472, 1989.
13. Senior, R. M., Griffin, G. L., Fliszar, C. J., Shapiro, S. D., Goldberg, G. I., and Welgus, H. G. Human 92-and 72 kilodalton type IV collagenases are elastases. J. Biol. Chem., 266:7870-7875,1991.
14. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner B.L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C., Bauer, E. A., and Goldberg, G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metal loproteinase capable of degrading basement membrane collagen. J. Biol. Chem., 263:6579-6587,1988.
15. Wilhelm, S. M., Collier, I. E., Manner, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem., 264:17213-17221, 1989.
16. Huhtala, P., Chow, L. T., and Tryggvason, K. Structure of the human type IV collagenase gene. J. Biol. Chem., 265:11077-11082,1990.
17. Huhtala, P., Eddy, R. L., Fan, Y. S., Byers, M. G., Shows, B., and Tryggvason, K. Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. Genomics, 6:554-559, 1990.
18. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., and Tryggvason, K. Complete structure of the human gene for 92-kDa type IV collagenase: divergent regulation of expression for the 92-kDa and 72-kDa enzyme genes in HT-1080 cells. J. Biol. Chem., 266:16485-16490,1991.
19. Liotta, L. A., Tryggvason, K., Garbisa, S., Foltz, C. M., and Shafie, S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature (Lond.), 284:67-68,1980.
20. Salo, T., Liotta, L. A., Keski-Oja, J., Turpeenniiemi-Hujanen, T., and Tryggvason, K. Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells-role in metastasis. Int. J. Cancer, 30:669-673,1982.
21. Starkey, J. R., Hosick, H. L., Stanford, D. R., and Liggitt, H. D. Interaction of metastatic tumor cells with bovine lens capsule basement membrane. Cancer Res., 44:1585-1594, 1984.
22. Turpeenniemi-Hujanen, T., Thorgeirsson, U. P., Hart, I. R., Grant, S. S., and Liotta, L. A. Expression of collagenase IV (basement membrane colla-genase) activity in murine tumor cell hybrids that differ in metastatic potential. J. Nad. Cancer Inst., 75:99-103, 1985.
23. Garbisa, S., Pozzatti, R., Muschel, R. J., Saffiotti, U., Ballin, M., and Goldfarb, R. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ros but not c-Ha-ras plus Ad2-Ela. Cancer Res., 47:1523-1528,1987.
24. Ballin, M., Gomez, D. E., Sinha, C. C., and Thorgeirsson, U. P. ras Oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun., 154:832-838, 1988.
25. Ura, H., Bonffl, R. D., Reich, R., Reddel, R., Pfeifer, A., Harris, C. C., and Klein, A. J. P. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res., 49: 4615-4621,1989.
26. Yamagata, S., Tanaka, R., Ito, Y., and Shimizu, S. Gelatinase of murine metastatic tumor cells. Biochem. Biophys. Res. Commun., 158: 228-234, 1989.
27. Moll, U. M., Youngleib, G. L., Rosinski, K. B., and Quigley, J. P. Tumor promoter-stimulated M.,92,000 type IV collagenase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res., 50:6162-6170,1990.
28. Grøndahl-Hansen, J., Ralfkižr, E., Kirkeby, L. T., Kristensen, P., Lund, L. R., and Danø, K. Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am. J. Pathol., 138:111-117,1991.
29. Pyke, C., Kristensen, P., Ralfkižr, E., Grøndahl-Hansen, J., Eriksen, J., Blasi, F., and Danø, K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol., 138:1059-1067, 1991.
30. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Current Protocols in Molecular Biology. New York: John WUey & Sons, 1989.
31. Sanger, F., Nicklen, S., and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74:54-63, 1977.
32. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular cloning. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
33. Whitham, S. E., Murphy, G., Angel, P., Rahmsdorf, H. J., Smith, B., Lyons, A., Harris, T. J. R., Reynolds, J. J., Herrlich, P., and Docherty, A. J. P. Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem. J., 240:913-916, 1986.
34. Muller, D., Quantin, B., Gesnel, M. C., Millon-Collard, R., Abecassis, J., and Breathnach, R. The collagenase gene family in humans consists of at least four members. Biochem. J., 253:187-192,1988.
35. Saus, J., Quinones, S., Otani, Y., Nagase, H., Harris, E. D., and Kurkinen, M. The complete primary structure of human matrix metalloprotemase-3: identity with stromelysin. J. Biol. Chem., 263:6742-6745,1988.
36. Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhqcer, O. L., Chenard, M. P., Rio, M. C., and Chambon, P. A new member of the metalloproteinase gene family is specifically expressed in stromal but not in tumor cells of breast carcinomas. Nature (Lond.), 348: 699-704, 1990.
37. Hasty, K. A., Pourmotabbed, T. F., Goldberg, G. I., Thompson, J. P., Spinella, D. G., Stevens, R. M., and Mainardi, C. L. Human neutrophil collagenase: a distinct gene product with homology to other matrix metallo-proteinases. J. Biol. Chem., 265:11421-11424,1990.
38. Salo, T., Turpeenniemi-Hujanen, T., and Tryggvason, K. Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J. Biol. Chem., 260:8526-8531, 1985.
39. Barsky, S. H., Grossman, D. A., and Bhuta, S. Desmoplastic basal cell carcinomas possess unique basement membrane-degrading properties. J. Invest. Dermatol., 88:324-329,1987.
40. Levy, A. T., Cioce, V., Sobel, M. E., Garbisa, S., Grigioni, W. F., Liotta, L. A., and Stetler-Stevenson, W. G. Increased expression of the Mt 72,000 type-IV collagenase in human colonic adenocarcinoma. Cancer Res., 51: 439-444, 1991.
41. Monteagudo, C., Merino, M. J., San-Juan, J., Liotta, L. A., and Stetler-Stevenson, W. G. Immunohistochemical distribution of type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol., 136: 585-592,1990.
42. Henry, N., Lamsweerde, A-L., and Vaes, G. Collagen degradation by metastatic variants of Lewis lung carcinoma: cooperation between tumor cells and macrophages. Cancer Res., 43:5321-5327,1983.
43. Bauer, E. A., Gordon, J. M., Reddick, M. E., and Eisen, A. Z. Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J. Invest. Dermatol., 69:363-367,1977.
44. Ellis, V., and Danø, K. Plasminogen activation by receptor-bound urokinase. Semin. Thromb. Haemost., 17:194-200,1991.
45. Pyke, C., Kristensen, P., Ralfkižr, E., Eriksen, J., and Dane, K. The plasminogen activation system in human colon cancer messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma. Cancer Res., 57:4067-4071,1991.